TR is used with a proper diet and exercise program to control high blood sugar in people with type 2 diabetes. Controlling high blood sugar helps prevent kidney damage, blindness, nerve problems, loss of limbs, and sexual function problems.作用机制：It works to stimulate first- and second-phase insulin secretion, and reduces glucagon levels, both in a glucose-dependent manner. Tr was also shown to delay gastric emptying, lower fasting and postprandial glucose concentration, decrease food intake, 4 and reduce body weight in patients with type 2 diabetes.潜在的研究应用食欲控制和饱腹感研究血糖和胰岛素敏感性研究肥胖和代谢综合征模型GLP-1受体途径调节研究Tr mechanism of action: effects on endocrine function and insulin resistance in patients with type 2 diabetes. Tr is a novel glucose-dependent insulinotropic polypeptide and glucagon-like peptide 1 (GLP-1) receptor agonist approved in the United States as an adjunct to diet and exercise to improve glycaemic control in adults with type 2 diabetes. It is under investigation for use in chronic weight management, major adverse cardiovascular events, and the management of other conditions, including heart failure with preserved ejection fraction, obesity, and non-cirrhotic non-alcoholic steatohepatitis. The Phase 3 SURPASS 1-5 clinical trial programme was designed to assess the efficacy and safety of once-weekly subcutaneously injected tr (5, 10, and 15 mg), as monotherapy or combination therapy, across a broad spectrum of people with type 2 diabetes.Use of tr in clinical studies was associated with marked reductions in glycated haemoglobin (-1.87 to -2.59%, -20 to -28 mmol/mol) and body weight (-6.2 to -12.9 kg), as well as reductions in parameters commonly associated with heightened cardiometabolic risk such as blood pressure, visceral adiposity, and circulating triglycerides. In SURPASS-2, these reductions were greater than those with the GLP-1 receptor agonist se 1 mg. Tir was well tolerated, with a low risk of hypoglycaemia when used without insulin or insulin secretagogues, and showed a generally similar safety profile to the GLP-1 receptor agonist class. Accordingly, evidence from these clinical trials suggests that tr offers a new opportunity for the effective lowering of glycated haemoglobin and body weight in adults with type 2 diabetes.
Delivery: We have our own delivery channels, and we are responsible for customs clearance and 100% delivery of the goods to your doorstep.(FedEx/USPS/UPS/DHL by air or sea)
Payment: Paypal, Western Union, Bank transfer, Bitcoin and USDT.
高品质，有竞争力的价格，充足的库存和快速交货有竞争力的价格。
送货及付款
Delivery: We have our own delivery channels, and we are responsible for customs clearance and 100% delivery of the goods to your doorstep.(FedEx/USPS/UPS/DHL by air or sea)
Payment: Paypal, Western Union, Bank transfer, Bitcoin and USDT.
